Literature DB >> 1446597

Paracrine regulation of adipose differentiation by arachidonate metabolites: prostaglandin F2 alpha inhibits early and late markers of differentiation in the adipogenic cell line 1246.

G Serrero1, N M Lepak, S P Goodrich.   

Abstract

The effect of arachidonate metabolites on the differentiation of the adipogenic cell line 1246 was investigated. Among the metabolites examined, only prostaglandin F2 alpha (PGF2 alpha) inhibited differentiation in a dose-dependent fashion with an ED50 of 3 x 10(-9) M. PGF2 alpha inhibited the mRNA expression of lipoprotein lipase, clone 154, and fatty acid-binding protein, which are early markers of differentiation, as well as glycerol-3-phosphate dehydrogenase specific activity and triglyceride accumulation, which are late markers of differentiation. Chronic exposure of 1246 cells to PGF2 alpha before and during differentiation indicated that the cells that have just initiated their differentiation program were the most susceptible to the inhibitory effect of PGF2 alpha. Since 1246 cells produce PGs, we determined whether the PG produced by the cells influenced adipose differentiation. Cyclooxygenase inhibitors added to the culture medium stimulated differentiation of 1246 cells up to 18-fold depending on the type and concentration of inhibitor used. In contrast, lipoxygenase inhibitors had no effect. Treatment of 1246 cells with arachidonic acid resulted in a dose-dependent inhibition of cell differentiation. Oleate or linoleate had no effect. These data indicate that PGF2 alpha inhibits early and late events of adipose differentiation and that the endogenous production of PGs (particularly PGF2 alpha) plays an important role as a negative paracrine or autocrine regulatory pathway of adipose differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446597     DOI: 10.1210/endo.131.6.1446597

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Genes involved in obesity: Adipocytes, brain and microflora.

Authors:  L Macia; O Viltart; C Verwaerde; M Delacre; A Delanoye; C Grangette; I Wolowczuk
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

2.  Anandamide-derived prostamide F2α negatively regulates adipogenesis.

Authors:  Cristoforo Silvestri; Andrea Martella; Neil J Poloso; Fabiana Piscitelli; Raffaele Capasso; Angelo Izzo; David F Woodward; Vincenzo Di Marzo
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

3.  Stimulation of adipose differentiation related protein (ADRP) expression by ibuprofen and indomethacin in adipocyte precursors and in adipocytes.

Authors:  H Ye; G Serrero
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

4.  Increased hepatic delta 6-desaturase activity with growth hormone expression in the MG101 transgenic mouse.

Authors:  M T Nakamura; S D Phinney; A B Tang; A M Oberbauer; J B German; J D Murray
Journal:  Lipids       Date:  1996-02       Impact factor: 1.880

5.  Aldo-Keto Reductases 1B in Endocrinology and Metabolism.

Authors:  Emilie Pastel; Jean-Christophe Pointud; Fanny Volat; Antoine Martinez; Anne-Marie Lefrançois-Martinez
Journal:  Front Pharmacol       Date:  2012-08-02       Impact factor: 5.810

6.  Overexpression of cyclooxygenase-2 in adipocytes reduces fat accumulation in inguinal white adipose tissue and hepatic steatosis in high-fat fed mice.

Authors:  Niels Banhos Danneskiold-Samsøe; Si Brask Sonne; Jeppe Madura Larsen; Ann Normann Hansen; Even Fjære; Marie Sophie Isidor; Sidsel Petersen; Jeanette Henningsen; Ilenia Severi; Loris Sartini; Yvonne Schober; Jacqueline Wolf; W Andreas Nockher; Christian Wolfrum; Saverio Cinti; Christian Sina; Jacob B Hansen; Lise Madsen; Susanne Brix; Karsten Kristiansen
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.